Quang Pham, DO
Facial Plastic Surgery · Lufkin, TXNPI 1376957589
Payments from drug & device makers
What this record shows
The money is spread across several categories — travel and lodging (57.4%), food and beverage and education — rather than concentrated in one kind of arrangement. 13 manufacturers reported payments, led by Medical Device Business Services, Inc. at 59.0% of the total. Reporting peaked in 2021 at $1,218 and has fallen 74.1% since, to $316 in 2025.
Across 23 payments — averaging $83.35 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Medical Device Business Services, Inc.$1K
- Smith+Nephew$170
- Sanofi-aventis U.S. LLC$99
- Neurent Medical Limited$87
- Intersect ENT, Inc.$73
- GSK$73
- plus $285 from 7 others
What the payments were for
- Travel & lodging$1,10057%
- Food & beverage$54829%
- Education$26914%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Medical Device Business Services, Inc. | 2 | $1,131 |
| Smith+Nephew | 1 | $170 |
| Sanofi-aventis U.S. LLC | 1 | $99 |
| Neurent Medical Limited | 2 | $87 |
| Intersect ENT, Inc. | 2 | $73 |
| GSK | 4 | $73 |
| Regeneron Healthcare Solutions, Inc. | 2 | $64 |
| Aerin Medical Inc. | 2 | $58 |
| Ambu Inc. | 2 | $58 |
| Cochlear Americas | 2 | $44 |
| Sanofi | 1 | $28 |
| Inspire Medical Systems, Inc. | 1 | $18 |
| Optinose US, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Coblation Wands$170
How this compares
$1,917 in reported general payments places this provider in the 60th percentile of 42 facial plastic surgery providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Ipratropium Bromide | 159 | $3,869 |
| Ciprofloxacin-DexamethasoneCiprofloxacin Hcl/Dexameth | 20 | $2,525 |
| Fluticasone Propionate | 105 | $1,386 |
| Famotidine | 151 | $794 |
| Pantoprazole Sodium | 76 | $457 |
| Ofloxacin | 22 | $422 |
| Levocetirizine Dihydrochloride | 59 | $244 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 16 | $106 |
| Prednisone | 24 | $61 |
Paid to pharmacies, not to this prescriber.
Other facial plastic surgery in Lufkin
- Jose BarreraSan Antonio$120K
- Eli GordinDallas$52K
- Ifeolumipo SofolaThe Woodlands$49K
- Vu HoPlano$33K
- Edward BuckinghamAustin$15K
- Tang HoHouston$4K
- Kent DavisHouston$4K
- Regina RodmanGalveston$4K
- Benjamin BassichisDallas$4K
- Rakan SaadounHouston$4K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.